Heo_2025_J.Nucl.Med__

Reference

Title : Preclinical Evaluation of (64)Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging - Heo_2025_J.Nucl.Med__
Author(s) : Heo GS , Nai YH , Otaegui JR , Yang S , Luehmann HP , Yuan G , Onthank D , Ennis M , Brown J , Lavine KJ , Gropler RJ , Liu Y
Ref : J Nucl Med , : , 2025
Abstract :

Fibroblast activation protein-expressing (FAP+) fibroblasts are central mediators of cardiac remodeling after injury or disease. The aim of this study was to evaluate a new PET tracer, (64)Cu-LNTH-1363S, to detect FAP+ fibroblasts in myocardial infarction (MI) mouse models. Methods: The permanent left anterior descending coronary artery ligation and the echocardiography-guided ischemia reperfusion models were used to assess the targeting efficiency of (64)Cu-LNTH-1363S. Competitive receptor blocking and autoradiography studies were performed to confirm the in vivo targeting specificity. Results: (64)Cu-LNTH-1363S demonstrated sensitive and specific detection of FAP+ cells in the 2 MI models. Kinetic modeling data showed that the distribution volume was higher in the infarct zone than in the remote myocardium. Conclusion: This study establishes the feasibility of (64)Cu-LNTH-1363S for noninvasive detection of FAP+ fibroblasts in MI mouse models and provides preclinical data to support further investigation of this process in humans after various forms of cardiac injury.

PubMedSearch : Heo_2025_J.Nucl.Med__
PubMedID: 41381234
Gene_locus related to this paper: human-FAP

Related information

Inhibitor LNTH-1363S
Gene_locus human-FAP

Citations formats

Heo GS, Nai YH, Otaegui JR, Yang S, Luehmann HP, Yuan G, Onthank D, Ennis M, Brown J, Lavine KJ, Gropler RJ, Liu Y (2025)
Preclinical Evaluation of (64)Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging
J Nucl Med :

Heo GS, Nai YH, Otaegui JR, Yang S, Luehmann HP, Yuan G, Onthank D, Ennis M, Brown J, Lavine KJ, Gropler RJ, Liu Y (2025)
J Nucl Med :